ETF Holdings Breakdown of HRMY

News associated with HRMY

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $53.63 Consensus PT from Brokerages

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month target price […] - 2025-06-24 05:36:53

Exchange Traded Concepts LLC Takes Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Exchange Traded Concepts LLC acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 30,256 shares of the company’s stock, valued at approximately $1,004,000. Exchange Traded Concepts LLC owned 0.05% of Harmony […] - 2025-06-20 08:16:57

Harmony Biosciences Holdings (HRMY) Shares Cross Below 200 DMA

In trading on Thursday, shares of Harmony Biosciences Holdings Inc (Symbol: HRMY) crossed below their 200 day moving average of $34.67, changing hands as low as $34.50 per share. Harmony Biosciences Holdings Inc shares are currently trading down about 1.6% on the day. The char - 2025-06-05 15:53:08

Squarepoint Ops LLC Has $582,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Squarepoint Ops LLC boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 125.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 16,901 shares of the company’s stock after purchasing an additional 9,411 shares during the period. Squarepoint Ops LLC’s holdings in Harmony Biosciences […] - 2025-06-04 08:06:50

Universal Beteiligungs und Servicegesellschaft mbH Invests $3.24 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 94,011 shares of the company’s stock, valued at approximately $3,235,000. Universal Beteiligungs und Servicegesellschaft mbH owned […] - 2025-06-03 08:10:48

Nuveen Asset Management LLC Has $7.31 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Nuveen Asset Management LLC lifted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 4.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 212,351 shares of the company’s stock after buying an additional 8,193 shares during the quarter. Nuveen Asset Management LLC’s holdings in Harmony Biosciences were worth […] - 2025-05-30 08:00:50

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Two Sigma Advisers LP

Two Sigma Advisers LP grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 21.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 98,900 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Two […] - 2025-05-27 09:37:02

ProShare Advisors LLC Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

ProShare Advisors LLC grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 47.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,190 shares of the company’s stock after purchasing an additional 4,534 shares during the period. […] - 2025-05-27 09:00:51

Bank of America Corp DE Lowers Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Bank of America Corp DE lessened its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 35.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 202,508 shares of the company’s stock after selling 113,458 shares during the quarter. Bank […] - 2025-05-27 08:16:49

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of “Buy” by Analysts

Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) have been given an average rating of “Buy” by the nine brokerages that are currently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average […] - 2025-05-27 05:48:52

Comerica Bank Has $464,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Comerica Bank grew its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 27.6% in the fourth quarter, HoldingsChannel reports. The fund owned 13,495 shares of the company’s stock after acquiring an additional 2,919 shares during the period. Comerica Bank’s holdings in Harmony Biosciences were worth $464,000 as of its most […] - 2025-05-16 08:20:57

Needham & Company LLC Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY)

Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $49.00 target price on the stock. Needham & Company LLC’s price target suggests a potential upside of 46.44% from the stock’s previous close. […] - 2025-05-08 07:40:44

Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up Following Better-Than-Expected Earnings

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report)’s share price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $29.96, but opened at $31.11. Harmony Biosciences shares last traded at $31.61, with a volume of 147,182 shares changing hands. The company reported […] - 2025-05-08 05:25:26

Analysts Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Target Price at $52.44

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock in […] - 2025-05-05 05:49:06

Barclays PLC Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Barclays PLC grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 31.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,872 shares of the company’s stock after purchasing an additional 24,010 shares during the […] - 2025-04-29 08:22:55

UBS Group Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price

Harmony Biosciences (NASDAQ:HRMY – Free Report) had its price target lowered by UBS Group from $55.00 to $48.00 in a research note released on Monday, MarketBeat.com reports. UBS Group currently has a buy rating on the stock. A number of other equities analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on […] - 2025-04-29 07:28:55

Envestnet Asset Management Inc. Raises Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Envestnet Asset Management Inc. raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 53,826 shares of the company’s stock after buying an additional 1,321 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Harmony Biosciences were worth $1,852,000 at […] - 2025-04-28 07:37:03

Legal & General Group Plc Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Legal & General Group Plc lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 27.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 116,959 shares of the company’s stock after buying an additional 25,338 shares during […] - 2025-04-23 08:19:04

Geode Capital Management LLC Has $31.08 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Geode Capital Management LLC raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 22.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 902,934 shares of the company’s stock after buying an additional 167,516 shares during the […] - 2025-04-17 07:53:09

Franklin Resources Inc. Has $1.10 Million Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Franklin Resources Inc. boosted its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 7.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,869 shares of the company’s stock after buying an additional 2,096 shares during […] - 2025-04-16 08:11:07

Norges Bank Makes New $16.12 Million Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Norges Bank bought a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor bought 468,410 shares of the company’s stock, valued at approximately $16,118,000. A number of other hedge funds have also made changes to their positions in the stock. JPMorgan Chase & […] - 2025-04-08 07:50:56

Arrowstreet Capital Limited Partnership Sells 20,948 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Arrowstreet Capital Limited Partnership reduced its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 6.6% in the 4th quarter, Holdings Channel reports. The firm owned 296,618 shares of the company’s stock after selling 20,948 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Harmony Biosciences were worth $10,207,000 as of its […] - 2025-04-06 08:28:53

Teacher Retirement System of Texas Buys 3,964 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Teacher Retirement System of Texas boosted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 50.6% in the fourth quarter, HoldingsChannel reports. The firm owned 11,801 shares of the company’s stock after acquiring an additional 3,964 shares during the period. Teacher Retirement System of Texas’ holdings in Harmony Biosciences were worth $406,000 […] - 2025-04-01 08:51:08

23,000 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Acquired by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 23,000 shares of the company’s stock, valued at approximately $791,000. Several other large investors have also recently modified […] - 2025-04-01 08:14:57

Amundi Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Amundi raised its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 243.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 18,402 shares of the company’s stock after buying an additional 13,041 shares during the quarter. Amundi’s holdings in Harmony Biosciences were worth $635,000 as of its most […] - 2025-03-21 08:39:12

Mizuho Raises Harmony Biosciences (NASDAQ:HRMY) Price Target to $44.00

Harmony Biosciences (NASDAQ:HRMY – Get Free Report) had its price target lifted by equities research analysts at Mizuho from $42.00 to $44.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho’s target price points to a potential upside of 27.91% from the stock’s […] - 2025-03-20 06:48:59

Handelsbanken Fonder AB Boosts Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Handelsbanken Fonder AB lifted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 19.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,500 shares of the company’s stock after acquiring an additional 2,200 shares during the […] - 2025-03-03 08:52:53

Harmony Biosciences (NASDAQ:HRMY) Receives “Buy” Rating from Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research report report published on Tuesday,Benzinga reports. The firm currently has a $50.00 price target on the stock. Several other equities research analysts have also weighed in on the company. Deutsche Bank Aktiengesellschaft initiated coverage on […] - 2025-02-26 08:56:55

New York State Teachers Retirement System Has $1.09 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

New York State Teachers Retirement System raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 31,693 shares of the company’s stock after buying an additional 809 shares during the period. New York State Teachers Retirement System’s holdings in Harmony Biosciences […] - 2025-02-24 08:57:05

Needham & Company LLC Cuts Harmony Biosciences (NASDAQ:HRMY) Price Target to $50.00

Harmony Biosciences (NASDAQ:HRMY – Get Free Report) had its price target cut by stock analysts at Needham & Company LLC from $52.00 to $50.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s target price points to a potential upside […] - 2025-02-21 08:18:53

HRMY institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	32,240	USD 1,027,166
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	4,105	USD 130,785
2025-06-26	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	55,238	USD 1,759,883
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	28,998	USD 923,876
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	28,998	USD 923,876
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	248	USD 7,901
Total =		149,827	USD 4,773,487

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer